Author:
Lin Binwei,Du Huan,Fan Jinjia,Huang Dan,Gao Feng,Li Jie,Zhang Yu,Feng Gang,Dai Tangzhi,Du Xiaobo
Abstract
The prognosis of advanced malignant tumors is very poor, and effective treatment is limited. Radioimmunotherapy (RIT) is a novel treatment method. However, its anti-tumor effect is relatively low in solid tumors, which is mainly due to the blood-tumor barrier preventing RIT from penetrating the tumor, resulting in an insufficient dose. Low-intensity ultrasound with microbubbles (USMB) has proven capable of opening the blood-tumor barrier. The combination of the two technologies may overcome the poor anti-tumor effect of RIT and promote the clinical application of RIT in solid tumors. In this article, we reviewed the current research status of RIT in the treatment of solid tumors and the opportunities and challenges of USMB combined with RIT.
Reference72 articles.
1. Mortality, Morbidity, and Risk Factors in China and Its Provinces, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017;Zhou;Lancet,2019
2. Cancer Survival in China, 2003-2005: A Population-Based Study;Zeng;Int J Cancer,2015
3. Monoclonal Antibodies for Cancer Immunotherapy;Weiner;Lancet,2009
4. Preclinical Optimization of Antibody-Based Radiopharmaceuticals for Cancer Imaging and Radionuclide Therapy-Model, Vector, and Radionuclide Selection;Carter;J Label Comp Radiopharm,2018
5. Both Complexity and Location of DNA Damage Contribute to Cellular Senescence Induced by Ionizing Radiation;Zhang;PloS One,2016
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献